RNA antagonist compounds for the modulation of HER3

Details for Australian Patent Application No. 2008250033 (hide)

Owner Enzon Pharmaceuticals, Inc.

Inventors Hedtjarn, Maj

Agent Griffith Hack

Pub. Number AU-A-2008250033

PCT Pub. Number WO2008/138904

Priority 60/917,392 11.05.07 US; 61/023,250 24.01.08 US

Filing date 9 May 2008

Wipo publication date 20 November 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/138904 Priority application(s): WO2008/138904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008250037-Delivery device

2008250020-Yield enhancement in plants by modulation of ZmPKT